City of Hope National Medical Center, Duarte, Calif., has named Michael Friedman, a physician and former acting commissioner of the Food and Drug Administration, as its president and CEO, effective immediately. Friedman, 59, acting FDA commissioner under President Clinton, most recently was senior vice president of research and development at Pharmacia Corp., which was acquired by Pfizer last month. He also has served as chief medical officer for biomedical preparedness at the Pharmaceutical Research and Manufacturers of America and associate director at the National Cancer Institute of the National Institutes of Health. Friedman replaces Gil Schwartzberg, who remains chairman emeritus. City of Hope is a research and treatment center for cancer, diabetes, AIDS and other serious illnesses. In June 2002, the 165-bed medical center won a $500 million jury award in a dispute with its former partner, biotechnology firm Genentech, over research on DNA technology. -- by Laura B. Benko
City of Hope taps former FDA official as new CEO
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.